Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Merrill Garrett A"'
Autor:
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C. Wolff, Katherine Reeder-Hayes, Hope S. Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta Liu, Kathryn J. Ruddy, Yue Zheng, Shoshana M. Rosenberg, Richard D. Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann Partridge, Eric P. Winer, Ian Krop, Sara M. Tolaney
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract The excellent outcomes seen in patients treated with adjuvant trastuzumab emtansine (T-DM1) in the ATEMPT trial and the favorable toxicity profile associated with this agent make T-DM1 a potential therapeutic option for select patients with
Externí odkaz:
https://doaj.org/article/e88fcc1488804534afd42026e28dc869
Autor:
P. Kelly Marcom, Ann H. Partridge, Hope S. Rugo, Ron Bose, Denise A. Yardley, Douglas Weckstein, Katherine E. Reeder-Hayes, Harold J. Burstein, Michael Constantine, Rita Nanda, Jiani Hu, Patricia DeFusco, Nadine Tung, William T. Barry, Ian E. Krop, Chau T. Dang, Bhuvaneswari Ramaswamy, Frederick Briccetti, Vijayakrishna K. Gadi, V. Valero, Lorenzo Trippa, Sara M. Tolaney, Kit L. Cheng, Eric P. Winer, Antonio C. Wolff, Lowell L. Hart, Michelle Demeo, Blair Ardman, Steven J. Isakoff, Bryan P. Schneider, Kathryn J. Ruddy, Therese M. Mulvey, Rachel C. Jankowitz, Meredith Faggen, Dan Sayam Zuckerman, Kathy S. Albain, A. Merrill Garrett
Publikováno v:
Cancer Research. 80:P2-13
Background: CRA is a surrogate for ovarian toxicity and associated risk of infertility and long-term menopausal symptoms. Therefore, it is important to assess and report the rate of CRA when we study a new neoadjuvant treatment regimen. In the Adjuva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d0d297ed01e27f0feaa7d331abee35
https://doi.org/10.1158/1538-7445.sabcs19-p2-13-02
https://doi.org/10.1158/1538-7445.sabcs19-p2-13-02
Autor:
Paolo Tarantino, Nabihah Tayob, Chau T Dang, Denise Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Douglas Weckstein, Antonio C. Wolff, Katherine Reeder-Hayes, Hope Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Audrey Merrill Garrett, Paul K. Marcom, Kathy S. Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta C. Liu, Kathryn Ruddy, Yue Zheng, Romualdo Barroso-Sousa, Adrienne Waks, Michelle K. DeMeo, Molly K. DiLullo, Giuseppe Curigliano, Harold Burstein, Ann Partridge, Eric Winer, Giuseppe Viale, Winnie Hui, Elizabeth A. Mittendorf, Bryan P. Schneider, Aleix Prat, Ian Krop, Sara Tolaney
Publikováno v:
Cancer Research. 83:PD18-01
Background: The ATEMPT trial primary analysis found that one year of adjuvant trastuzumab emtansine (T-DM1) achieved a 3-year iDFS of 97.8% for patients with stage I HER2+ breast cancer, but was not associated with fewer clinically relevant toxicitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85dc5c0c6947eee6406ca29989d747df
https://doi.org/10.1158/1538-7445.sabcs22-pd18-01
https://doi.org/10.1158/1538-7445.sabcs22-pd18-01
Autor:
Lowell L. Hart, Michelle Demeo, Minetta C. Liu, P. Kelly Marcom, Ron Bose, Douglas Weckstein, Ann H. Partridge, Blair Ardman, A. Merrill Garrett, Rita Nanda, Catherine Van Poznak, Andres Forero-Torres, Vicente Valero, Hope S. Rugo, Jiani Hu, Dan Sayam Zuckerman, Yue Zheng, Sara M. Tolaney, Eric P. Winer, Nabihah Tayob, Katherine E. Reeder-Hayes, Kit Cheng, Harold J. Burstein, Chau T. Dang, Patricia DeFusco, Vijayakrishna K. Gadi, Ian E. Krop, Therese M. Mulvey, Bryan P. Schneider, Rachel C. Jankowitz, Mothaffar F. Rimawi, Frederick Briccetti, Shoshana M. Rosenberg, Kathryn J. Ruddy, Nadine Tung, Vandana G. Abramson, Steven J. Isakoff, Tal Sella, Meredith Faggen, Bhuvaneswari Ramaswamy, Antonio C. Wolff, Paula R. Pohlmann, Michael Constantine, Kathy S. Albain, Denise A. Yardley
Publikováno v:
Breast cancer research and treatment. 189(1)
Chemotherapy-related amenorrhea (CRA) is a surrogate for ovarian toxicity and associated risk of infertility and premature menopause. Here, we compare CRA rate with paclitaxel (T)-trastuzumab (H) to that with ado-trastuzumab emtansine (T-DM1). Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f951bc6f1e660e452ab3f630355206e
https://pubmed.ncbi.nlm.nih.gov/34120223
https://pubmed.ncbi.nlm.nih.gov/34120223
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sharon L. LaBrie, Andrew J. Pritchard, Sandra T. Sigmon, Christine M. Fink, Robert J. Ferguson, Rachel E. Goetze, A. Merrill Garrett
Publikováno v:
Cancer. 122:1782-1791
Background Long-term chemotherapy-related cognitive dysfunction (CRCD) affects a large number of cancer survivors. To the authors' knowledge, to date there is no established treatment for this survivorship problem. The authors herein report results o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ceb977f840396d3e2e858f93a0fa1d6
https://doi.org/10.1002/cncr.29891
https://doi.org/10.1002/cncr.29891
Autor:
Merrill Garrett
Publikováno v:
Perspectives on Mental Representation ISBN: 9781315521930
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8e218473f360b3bfadfff9449043fec
https://doi.org/10.4324/9781315521930-20
https://doi.org/10.4324/9781315521930-20
Autor:
Robert J, Ferguson, Sandra T, Sigmon, Andrew J, Pritchard, Sharon L, LaBrie, Rachel E, Goetze, Christine M, Fink, A Merrill, Garrett
Publikováno v:
Cancer. 122(11)
Long-term chemotherapy-related cognitive dysfunction (CRCD) affects a large number of cancer survivors. To the authors' knowledge, to date there is no established treatment for this survivorship problem. The authors herein report results of a small r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d22710e348a1aa2d261d268a2a7f1c3
https://pubmed.ncbi.nlm.nih.gov/27135464
https://pubmed.ncbi.nlm.nih.gov/27135464
Publikováno v:
Applied Psycholinguistics. 27:74-81
We join other responders in thanking Clahsen and Felser (CF) for pulling together these observations about the development of language processing. We are especially impressed by the generality and inclusiveness of CF's treatment of development in L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f75b315eefabb0352f3fa955116ae55
https://doi.org/10.1017/s0142716406060139
https://doi.org/10.1017/s0142716406060139
Autor:
Merrill Garrett
Publikováno v:
Cognition. 42:143-180
Errors in lexical processing are commonplace in language pathologies resulting from brain injury or disease. This discussion considers some of the major recent developments in the interpretation of such errors. The focus is on behavioral systems, rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0228566f6ced4c82654b286eefd916ab
https://doi.org/10.1016/0010-0277(92)90042-g
https://doi.org/10.1016/0010-0277(92)90042-g